Jean-Yves Pavee, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 4,871 shares at $46.41 ($88K) on 2015-02-17, disclosed to the SEC on 2015-02-18.
Scheduled sale ($88k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,966 | $0 | 0.0% |
| 2 | $46.09 | 1,001 | $46K | 52.4% |
| 3 | $46.09 | 283 | $13K | 14.8% |
| 4 | $46.41 | 621 | $29K | 32.8% |
| Total | $18.07 avg | 4,871 | $88K | 100% |
| Filing → |
| ABT | SELL | 2015-06-05 | $515K | — | Filing → |
| ABT | SELL | 2015-03-03 | $31K | — | Filing → |
| ABT | SELL | 2014-02-19 | $19K | — | Filing → |